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Abstract
The thermotropic and dynamic properties of the biologically active v8-tetrahydrocannabinol (v8-THC) and its inactive
congener O-methyl-v8-tetrahydrocannabinol (Me-v8-THC) in DPPC/cholesterol (CHOL) bilayers have been studied using a
combination of DSC and solid-state NMR spectroscopy. The obtained results showed differential effects of the two
cannabinoids under study. These are summarized as follows: (a) the presence of the active compound fluidizes more
significantly the DPPC/CHOL bilayers than the inactive analog as it is revealed by DSC and NMR spectroscopy results; (b)
cholesterol seems to play a significant role in the way cannabinoids act in membrane bilayers ; (c) the observed additional
peaks in 13C/MAS-NMR spectra which were cannabinoid specific offer an evidence of their different dynamic properties in
membranes. In particular, the aromatic part of the inactive cannabinoid appears more mobile than that of the active one.
This finding is in agreement with previously obtained X-ray data which locate the inactive cannabinoid in the hydrophobic
core of the bilayer while the active one in the polar region; and (d) the observed downfield shift of C-1 carbon in the
preparation containing the active cannabinoid is a strong evidence that v8-THC resides nearby the polar region where also
cholesterol is well known to locate itself. Such downfield shift is absent when Me-v8-THC is resided in the membrane bilayer.
These differential effects of the two cannabinoids propose that the phospholipid/cholesterol core of the membrane may play
an important role in the mode of cannabinoid action by regulating their thermotropic and dynamic properties. ß 1999
Elsevier Science B.V. All rights reserved.
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1. Introduction
It has been argued in the literature that lipophilic
compounds are energetically favored to act on their
receptor through membrane bilayers. In particular,
theoretical di¡usion limited rates of drugs approach
to the receptor through membrane pathway are ap-
proximately three orders of magnitude greater than
aqueous di¡usion through the bulk solvent [1,2]. The
following experimental observations support a mem-
brane bilayer pathway for 1,4-dihydropyridine deriv-
atives (DHP). Patch-clamp studies with neonatal rat
ventricular cells show that DHP derivatives added to
the medium outside of the patch are still capable of
binding and blocking single calcium channels within
the patch [3]. In a study, drug di¡usion within the
membrane was demonstrated using Ca2 channels in
lipid planar bilayers. Thus, DHP, Bay K 8644 and
phenylalkylamine D-600 must cross the lipid bilayer
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in order to bind with speci¢c sites in asymmetrically
arranged Ca2 receptors [4].
Cannabinoids are also highly lipophilic molecules
and therefore may reach their speci¢c receptor site
through a two-step mechanism involving lipid inter-
action and lateral di¡usion.
The above hypothesis is enhanced by the fact that
not all physiological e¡ects of cannabinoids can be
attributed to the existence of receptors. Instead, some
are clearly shown to be modulated through their in-
teractions on cellular membranes [5^8].
Further evidence for the proposed mechanism can
be provided by studying drug: membrane interac-
tions. Thus, if these interactions are speci¢c and ac-
count for the biological activity of drugs under study
then the above mechanism of action gains a biolog-
ical signi¢cance.
DPPC bilayers is a partially successful system in
establishing structure activity relationships between
biological activity and thermodynamic parameters
as shown in our previous publication using DSC
and X-ray di¡raction [9]. Hitherto, DPPC bilayers
were used in our studies for mainly two reasons:
(a) DPPC bilayers which are spontaneously formed
when the phospholipid is hydrated were studied ex-
tensively using various biophysical methods; and (b)
DPPC bilayers consist a simple model that allows to
study the physical chemical parameters that govern
drug^membrane interactions. However, DPPC/cho-
lesterol system is a more distinctive system and can
account for more subtle di¡erential dynamic or ther-
motropic changes caused by the additives [10].
It has been chosen to ¢rst study in detail the e¡ects
of the biologically active v8-tetrahydrocannabinol
(v8-THC) and its inactive congener O-methyl-v8-tet-
rahydrocannabinol (Me-v8-THC) (Fig. 1) in model
DPPC membrane using a combination of di¡erential
scanning calorimetry (DSC), 13C/MAS-NMR and
13C/CP/MAS-NMR as well as 31P-NMR spectros-
copy [11]. The rationale for choosing this pair of
cannabinoid analogs is that it o¡ers a system in
which the role of amphipathicity of a molecule can
be studied. For example, v8-THC possess a phenolic
hydroxyl group which gives it the possibility for am-
photeric interactions. However, the inactive O-meth-
yl analog lacks of this capability. The importance of
the C-1 substituent in classical cannabinoids to CB2
receptor selectivity has been recently studied [12]. We
believe that such a system is ideal for studying drug^
membrane interactions in general. This is because it
is known for other drug classes that derivatization of
the phenolic hydroxyl groups has tremendous conse-
quences in drug activity [13,14].
The obtained results showed di¡erential e¡ects of
the two cannabinoids under study in the DPPC mod-
el membrane which may in part explain their di¡er-
ent biological activity. These results coupled with
previous results using X-ray and neutron di¡raction
as well as solid state 2H-NMR spectroscopy build a
model for the interactions of this pair of cannabi-
noids into the membrane bilayers consisting of the
following characteristics: (a) v8-THC is located near
the membrane interface with its phenolic hydroxyl
group anchored near the esteri¢ed carbonyl groups
of phosphatidylcholines, while the more lipophilic
Me-v8-THC is located deeper in the membrane bi-
layer [15^17]; (b) solid state 2H-NMR data have
shown that v8-THC orients itself with the long axis
of the tricyclic structure perpendicular to the bilayer
chains while Me-v8-THC was shown to assume an
Fig. 1. Chemical structures of DPPC, v8-THC, Me-v8-THC
and cholesterol.
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orientation in which the long axis of the tricyclic
structure, is parallel to the lipid chains [18] ; (c)
13C/MAS-NMR and 13C/CP/MAS-NMR spectros-
copy gave direct evidence of the intercalation of
both molecules into the membrane bilayers due to
the speci¢c additional peaks appeared in the
DPPC/v8-THC or DPPC/Me-v8-THC preparations
attributed solely to the added cannabinoid. The dif-
ferent peaks appeared in the 13C/MAS-NMR and
13C/CP/MAS-NMR spectra due to the presence of
either cannabinoid showed their di¡erent mobility
in DPPC bilayers [11]; and (d) 31P-NMR spectros-
copy revealed that the presence of the active analog
causes signi¢cant conformational changes in the vi-
cinity of the headgroup while the inactive analog
only minor changes.
This article is an extension of our research activity
focusing on the interactions of this pair of cannabi-
noids in membranes containing phospholipid with
cholesterol using a combination of DSC and solid
state NMR spectroscopy. The signi¢cance of this
manuscript can be summarized as follows: (a) the
membrane under study resembles closer to the bio-
logical one. Therefore, any observed di¡erential ef-
fects between the two analogs under study in DPPC/
cholesterol (DPPC/CHOL) bilayers would enhance
the hypothesis that cannabinoids, a highly lipophilic
class of molecules, may reach the receptor site prob-
ably by interacting productively with phospholipid
core containing cholesterol. This phospholipid core
may in fact mediate and control their biological ac-
tion; (b) this study provides key information about
the role of cholesterol in the cannabinoid molecular
mechanism of action; and (c) it provides physical
chemical information about the dynamic and ther-
motropic properties of a hydrated ternary system.
2. Materials and methods
2.1. Materials
Dipalmitoyl-glycero-sn-3-phosphorylcholine
(DPPC) was obtained from Avanti Polar Lipids,
Inc., AL, USA and cholesterol from Sigma. v8-
THC and Me-v8-THC were kindly donated by
Prof. A. Makriyannis laboratory.
2.2. Methods
2.2.1. DSC
Sample preparation procedures were identical for
DSC and NMR spectroscopy. Appropriate amounts
of the phospholipid/CHOL with or without cannabi-
noid were dissolved in spectroscopic grade chloro-
form. The solvent was then evaporated by passing
a stream of O2-free nitrogen over the solution at
50‡C and the residue was placed under vacuum
(0.1 mm Hg) for 12 h. For measurements this dry
residue was dispersed in appropriate amounts of bi-
distilled water by vortexing. After dispersion in water
(50% w/w), portions of the samples (ca. 5 mg) were
sealed in stainless steel capsules obtained from Per-
kin^Elmer. Thermograms were obtained on a Per-
kin^Elmer DSC-7 calorimeter. Prior to scanning,
the samples were held above their phase transition
temperature for 1^2 min to ensure equilibration. All
samples were scanned at least twice until identical
thermograms were obtained, using a scanning rate
of 2.5‡C/min. The temperature scale of the calorim-
eter was calibrated using indium (Tm = 156.6‡C) as
standard sample. Thermograms from samples stored
at freezer temperatures (315‡C) for a few days were
identical if run immediately after sample preparation.
This signi¢es that thermal history of the sample does
not a¡ect the thermograms in this particular class of
drug molecules [19].
2.2.2. NMR spectroscopy
Stationary and high resolution NMR spectra were
obtained at 100.63 MHz on a Bruker MSL 400
NMR spectrometer capable of high-power 1H-decou-
pling and equipped with magic angle spinning unit.
The spinning rate for MAS NMR experiments used
was 2.5 kHz, and was kept constant for the two
temperatures (25 and 37‡C). Each spectrum was an
accumulation of 2000 scans for the stationary spectra
and 20 000 scans for the high resolution spectra. The
lipid content for the three samples used in the experi-
ments was the same (V50 mg). The delay time was
4 s, the 90‡ pulse width was 5 Ws and the acquisition
time was 40 ms. Chemical shifts values of DPPC
bilayers were obtained from literature [20]. Peak as-
signments attributed to the drugs are based on their
13C high resolution data in solution [11].
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3. Results
3.1. Di¡erential scanning calorimetry
Di¡erential scanning calorimetry (DSC) is a fast
and relatively inexpensive thermodynamic technique
which allows the study of the thermotropic proper-
ties of the membranes in the absence and presence of
bioactive molecules. Therefore, it is used in our lab-
oratory as a diagnostic technique to investigate dif-
ferential e¡ects that may be caused by the incorpo-
ration of additives under study. When such
di¡erential e¡ects are observed, then techniques
which o¡er complementary and more detailed infor-
mation on the thermal and dynamic properties of
membranes, with or without the presence of additives
are applied. Fig. 2 shows DSC scans of DPPC/
CHOL without or with the presence of either canna-
binoid under study. The DPPC/CHOL (x = 0.20 or
80:20 molar ratio) scan shows a phase transition
which consists of a narrow low temperature and a
broad high temperature components. The narrow
component consists mainly of a pool containing
DPPC and the broad component of a pool contain-
ing mainly cholesterol [21]. The addition of x = 0.05
v8-THC relative to DPPC in DPPC/CHOL bilayers
a¡ects its narrow component by signi¢cantly broad-
ening it (Fig. 2) while the addition of Me-v8-THC
has a smaller e¡ect. The quantitative results for these
preparations are shown in Table 1. A progressive
addition of cannabinoid (x = 0.10) relative to DPPC
signi¢es the di¡erential e¡ects between the two can-
nabinoids. The active cannabinoid broadens further
Fig. 2. DSC scans of (a) DPPC/CHOL (x = 0.20) and the addi-
tion of (b) v8-THC (x = 0.05), (c) Me-v8-THC (x = 0.05), (d)
v8-THC (x = 0.10) and (e) Me-v8-THC (x = 0.10).
Table 1
Values of onset temperature (Tonset), half-width temperature (Tm1=2), peak temperature (Tm) and enthalpy change (vH) of DPPC/
CHOL, DPPC/CHOL/v8-THC and DPPC/CHOL/Me-v8-THC preparations
Samples Tonset (‡C) vH (kcal/mol) Tm1=2 (‡C) Tm (‡C)
DPPC+CHOL (x = 0.20) 39.0 14.8 3.1 40.5
DPPC+CHOL+v8-THC (x = 0.05) 33.0 20.6 11.2 40.2
DPPC+CHOL+Me-v8-THC (x = 0.05) 36.5 15.9 7.6 40.9
DPPC+CHOL+v8-THC (x = 0.1) 25.7 18.2 19.0 28.5 39.3
DPPC+CHOL+Me-v8-THC (x = 0.1) 35.6 15.1 8.7 40.1
DPPC+CHOL (x = 0.15) 40.1 15.8 3.2 41.8
DPPC+CHOL+v8-THC (x = 0.2) 25.4 25.4 13.5 27.9 35.3
DPPC+CHOL+Me-v8-THC (x = 0.2) 33.1 26.1 8.0 37.8 39.5
DPPC+CHOL (x = 0.30) 37.0 7.0 13.7 42.8
DPPC+CHOL+v8-THC (x = 0.2) 33.7 10.9 12.2 39.3
DPPC+CHOL+Me-v8-THC (x = 0.2) 28.9 7.6 14.0 42.8
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the phase transition of DPPC/CHOL giving a scan
with a sharp and broad maxima centered at 28.5 and
39.3‡C, respectively, while the inactive one shows a
saturation e¡ect (Table 1). Thus, the DSC scan con-
taining the inactive analog resembles the preparation
which contains only x = 0.05 of cannabinoid.
DPPC bilayers containing di¡erent concentration
of cholesterol (x = 0.15 and x = 0.30) and constant
concentration of cannabinoid (x = 0.20) relative to
DPPC were examined in an attempt to study the
e¡ects of cholesterol in these bilayers (Fig. 3). At
DPPC/CHOL (x = 0.15) preparation the presence of
the active cannabinoid broadens more signi¢cantly
the phase transition of DPPC/CHOL in comparison
to the inactive one and produces a more complex
thermogram [22^24]. The low temperature maximum
is split into two distinct maxima (27.9 and 35.3‡C,
37.8‡C and 39.5‡C) in the presence of an active and
inactive cannabinoid correspondingly.
When a higher concentration of cholesterol is used
(x = 0.3) only v8-THC a¡ects the phase transition of
DPPC/CHOL. The thermograms consist of only one
very broad peak. This is a well known e¡ect of cho-
lesterol which at increasing concentrations causes sig-
ni¢cant broadening and ¢nally abolishes the phase
transition of DPPC bilayers [21].
3.2. 13C-NMR spectroscopy
To gain more information about the structure of
the membrane bilayers and the e¡ects of cannabi-
noids when inserted into DPPC bilayers, solid state
13C-NMR spectroscopy was applied. In particular,
stationary 13C-NMR spectroscopy was utilized to
study the structure of membrane bilayers, while
high resolution 13C-NMR spectroscopy was per-
formed to explore the dynamic properties of drug
molecules in the membrane bilayer.
Solid-state 13C-NMR experiments were run at
temperatures of 25^43‡C for the three preparations
under study (Figs. 4 and 5). Each spectrum consists
of three regions, namely, carbon atoms in the hydro-
phobic region (10^40 ppm), those in the glycerol
backbone region (40^80 ppm), and the esteri¢ed car-
bonyls (near 170 ppm).
When a molecule is present in the phospholipid
bilayer it can cause the following changes to the 13
C-NMR spectrum. (a) Changes in peak intensity and
line-width due to modi¢ed membrane £uidity. (b)
Changes in chemical shift values of individual carbon
nuclei of the membrane lipid due to modi¢ed phase
transition pro¢les. (c) Appearance of a speci¢c subset
of peaks from the carbon nuclei of the incorporated
cannabinoid molecules. These spectral features will
be analyzed both qualitatively and quantitatively,
and the results will be combined with DSC experi-
ments to gain better understanding of the mem-
brane’s thermotropic properties induced by each of
the cannabinoids.
When the bilayer is below the phase transition (gel
Fig. 3. DSC scans of (a) DPPC/CHOL (x = 0.15) and the addi-
tion of (b) v8-THC (x = 0.20), (c) Me-v8-THC (x = 0.20), (d)
DPPC/CHOL(x = 0.30) and the addition of (e) v8-THC
(x = 0.20) and (f) Me-v8-THC (x = 0.20).
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phase) the carbonyl signal is broad and asymmetric.
Above the phase transition, where the £uidity of the
membrane is increased this peak becomes narrower.
Other peaks also above the phase transition become
narrower and additional peaks are resolved. Above
the main phase transition temperature several
changes are observed not only in the lineshape of
the peaks but also in their chemical shift. For exam-
ple, a large up¢eld shift of the (CH2)n peaks is ob-
served which re£ects an increase in the acyl chains
population of gauche conformations [25].
3.3. Stationary 13C-NMR spectroscopy
3.3.1. Carbonyl region
At 43‡C and ca. 172 ppm a peak is observed at-
tributed to the carbonyls (C-1P) signal from the phos-
pholipids in DPPC/CHOL (x = 0.20) bilayer (Fig. 4).
The presence of carbonyl group is already apparent
from the lower temperature of 25‡C when the active
cannabinoid is incorporated in DPPC/CHOL prepa-
ration. This, as it is explained above, indicates £uid-
ization e¡ect in DPPC/CHOL membrane by v8-THC
analog. The inactive analog exerts also a £uidizing
e¡ect but to a lesser degree because the carbonyl
peak appears only at 5‡C lower temperature vis a'
vis DPPC/CHOL preparation.
3.3.2. Hydrophobic and headgroup regions
The total halfwidth of the complex (CH2)n region
containing the various methylene resonances in the
three preparations is simulated for the representative
Fig. 4. Stationary 13C-NMR spectra of DPPC/CHOL (x = 0.20) without or with either (x = 0.20) active cannabinoid v8-THC and
(x = 0.20) inactive cannabinoid Me-v8-THC at temperature range of 25^43‡C.
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temperatures (25, 36 and 43‡C) using the LINESIM
program provided by Bruker company and incorpo-
rated into the NMR spectrometer. The complex
(CH2)n region was simulated considering that it con-
sists of three individual peaks. These are designated
in a representative peak of DPPC/CHOL/v8-THC
preparation at 43‡C as 1, 2 and 3 (Fig. 4). Analyti-
cally, the simulation results are shown in Table 2.
The major conclusions derived from this table are:
(a) using the total half width of the simulated peaks
as a comparison parameter it was found that this was
narrower in the active cannabinoid containing prep-
aration. This result indicates that the active cannabi-
noid causes the most £uidization in the DPPC/
CHOL bilayers; (b) the intensities of the simulated
peaks in the three preparations varied depicting once
more the distinct dynamic properties of the three
preparations; (c) the total halfwidth of the three
preparations was temperature dependent. The gener-
al trend was that increase of temperature caused re-
duction of the total halfwidth in the three prepara-
tions; and (d) the active cannabinoid containing
preparation contained more resolved peaks, signify-
ing again that this preparation was the most £uid.
The headgroup region of its spectrum contains
clearly three peaks versus only two observed in
DPPC/CHOL, or DPPC/CHOL/Me-v8-THC bi-
layers. The headgroup region is also better resolved
in the active cannabinoid containing membrane prep-
aration. The obtained DPPC/CHOL/Me-v8-THC
spectra resemble those of DPPC/CHOL bilayers.
3.3. High-resolution 13C-NMR spectroscopy
Representative 13C/MAS-NMR spectra for the
three preparations under study at temperatures of
Fig. 5. 13C/MAS-NMR spectra of hydrophobic and polar region of DPPC/CHOL (x = 0.20) without or with either (x = 0.20) active
cannabinoid v8-THC and (x = 0.20) inactive cannabinoid Me-v8-THC at temperatures of 25 and 37‡C.
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Table 2
Intensities, halfwidths (X1=2) and total widths of the simulated methylene peak (10^50 ppm) at representative temperatures of 25, 36
and 43‡C
Samples Temperature (‡C) Intensity % Half width (X1=2) Total width
Peak 1 Peak 2 Peak 3 Peak 1 Peak 2 Peak 3
DPPC/CHOL 25 15.9 14.3 69.8 907.81 397.53 1377.56 2682.9
36 14.3 18.9 66.8 703.22 496.37 1101.52 2301.1
43 16.6 24.2 59.2 591.24 631.23 1022.06 2245.5
DPPC/CHOL/v8-THC 25 13.9 18.1 68.1 408.91 492.90 948.80 1850.6
36 15.4 16.7 67.8 366.53 493.27 972.89 1832.7
43 15.6 22.9 61.5 377.15 520.30 868.43 1765.6
DPPC/CHOL/Me-v8-THC 25 16.5 19.3 64.2 680.53 455.33 1137.46 2273.3
36 19.0 16.7 64.3 567.15 340.47 1309.18 2246.8
43 10.3 11.1 78.6 387.04 175.58 1375.22 1937.8
Table 3
C-13 assignment of preparations DPPC/CHOL, DPPC/CHOL/v8-THC and DPPC/CHOL/Me-v8-THC
Assignment Chemical shifts
25‡C 37‡C
DPPC/
CHOL
DPPC/CHOL/
v8-THC
DPPC/CHOL/
Me-v8-THC
DPPC/
CHOL
DPPC/CHOL/
v8-THC
DPPC/CHOL/
Me-v8-THC
C-16P 12.47 12.47 12.47 12.36 12.35 12.35
C-15P 24.05 24.15 24.60 24.50 24.27 24.38
C-3 26.80 26.80 26.91 26.91 27.02 26.80
(CH2)10 30.88 30.44 30.22 30.66 30.44 30.44
C-2P 35.41 35.41 35.30 35.41 35.30 35.30
N(CH3)3 52.73 52.61 52.72 52.72 52.61 52.72
C-11 58.24 58.13 58.13 58.13 58.13 58.13
C-12 64.53 64.53 64.53 64.64 64.64 64.64
C-18 (ch) 12.00 11.13 11.13 12.30 11.02 10.90
C-21 (ch) 18.53 18.42 18.53 18.42 18.42 18.31
C-19 (ch) 21.07 20.96 21.07 20.96 21.07 20.96
C-11 (ch) 22.06 21.62 21.95 21.84 21.62 21.84
C-16 (ch) 41.15 41.14 41.25 41.25 41.14 41.14
C-5P 16.55 16.66
C-6a 43.57 43.57
C-6 74.01 74.01
C-2 100.92 100.92
108.64 108.97
C-4 109.85 109.85
C-8 117.79 117.57
C-9 132.79 133.67 132.79
C-3 139.96 140.07 139.96
C-4a 152.75 152.87
C-1 157.06 161.36 157.17
CNO 172.00 171.84 171.40
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25 and 37‡C are shown in Fig. 5. The preparations
containing cannabinoid show additional peaks due
to its presence in the membrane bilayers. Peaks due
to the presence of drug molecules are clearly shown
and labeled on the spectra (Table 3). For example,
the peak at 74 ppm which corresponds to C-6 of the
cannabinoid at 25‡C is only observed in the bilayer
containing the inactive cannabinoid. This peak is
also more pronounced in the bilayer containing the
inactive cannabinoid Me-v8-THC at 37‡C. These re-
sults show that the tricyclic part of the inactive can-
nabinoid is more mobile. Simulation of the X1=2 for
the representative peaks (C-12, C-11 and C-16P)
present at both temperatures of 25 and 37‡C in the
three preparations are shown in Table 4. The major
conclusions derived from this table are the following:
the X1=2 of the simulated peaks is temperature de-
pendent; all three simulated peaks become narrower
with increase of temperature. The presence of active
cannabinoid in DPPC/CHOL reduces considerably
X1=2 of peaks C-11 and C-12 at liquid crystalline
phase. This is in additional evidence which shows
that the active cannabinoid is placed at the vicinity
of the polar group. The presence of the almost in-
active cannabinoid at the liquid crystalline phase in
DPPC/CHOL reduces considerably X1=2 of peak C-
16P showing that is placed at the hydrophobic region.
Interestingly, the presence of almost inactive analog
reduces considerably X1=2 of the simulated peaks at
25‡C. In contrast, the presence of the active analog
reduces X1=2 of C-11 and increases X1=2 of C-12 and
C-16P.
The aromatic and carbonyl regions of the three
preparations are shown in Fig. 6. The DPPC/
CHOL bilayer contains a peak centered at 172 ppm
due to the carbonyl groups of DPPC. The presence
of either cannabinoid in DPPC/CHOL bilayers re-
sults in the sharpening and increasing of £uidization
of this bilayer. Several other peaks due to the pres-
ence of either cannabinoid in the aromatic region are
present (see also Table 3). These peaks are more
pronounced in DPPC/CHOL/Me-v8-THC bilayers
showing once again the higher mobility of this region
in the DPPC/CHOL bilayers. This observation con-
¢rms previous X-ray data which locate the inactive
analog deep in the hydrophobic core of the mem-
brane bilayer where it is anticipated to have a high
mobility. In contrast, the active one is found to an-
chor in the mesophase or headgroup of the DPPC
bilayers with a restricted motion. Peaks correspond-
ing to C-4, C-10b, C-8, C-4a and C-2 are evident
only in DPPC/CHOL/Me-v8-THC bilayer. This is a
nice application of 13C/MAS-NMR spectroscopy
which clearly shows a di¡erent molecular motion of
chemically similar drug molecules that have di¡erent
biological activity in cholesterol-containing mem-
brane bilayers.
Another striking evidence which positions the ac-
tive cannabinoid in the polar region is the down¢eld
shift of C-1 (161.36 ppm) observed in DPPC/CHOL/
v8-THC preparation at temperature of 37‡C. The
peak is clearly attributed to the cannabinoid because
in both DPPC bilayers alone and DPPC/CHOL bi-
layers the carbonyl peak resonates at 172 ppm [11].
This carbon is adjacent to phenolic hydroxyl group
and is expected to be sensitive to the local environ-
ment. This down¢eld shift was observed neither in
DPPC/CHOL preparation nor in DPPC/CHOL/Me-
v8-THC. Using aprotic or not solvents or prepara-
tions without cholesterol, this down¢eld shift was not
observed. It appears that the presence of cholesterol
contributes to the cause of this down¢eld shift. It is
probable that the presence of cholesterol shifts the
topography of the active cannabinoid upper in the
Table 4
Simulated X1=2 values of the representative peaks C-11, C-12 and C-16P at 25 and 37‡C of the preparations DPPC/CHOL, DPPC/
CHOL/v8-THC and DPPC/CHOL/Me-v8-THC
Samples Half width (X1=2)
C-12 C-11 C-16P
25‡C 37‡C 25‡C 37‡C 25‡C 37‡C
DPPC/CHOL 47.59 42.35 42.82 41.76 34.13 29.88
DPPC/CHOL/v8-THC 51.16 37.38 40.20 26.72 37.58 34.15
DPPC/CHOL/Me-v8-THC 49.22 37.66 39.06 32.31 33.48 29.44
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headgroup region of the membrane bilayers. This
shift may due to hydrogen bonding of the phenolic
hydroxyl group with the headgroups of the phospho-
lipid. The topography of the inactive Me-v8-THC
does not seem to be a¡ected by the presence of cho-
lesterol. A graphical representations of the obtained
results are shown in Figs. 7 and 8.
4. Discussion
We have applied a combination of DSC and solid-
state NMR spectroscopy to study the e¡ects of a pair
of cannabinoids in membrane bilayers. This pair of
cannabinoids is characterized by a distinct di¡erent
biological action. Thus, v8-THC is an active psycho-
tropic cannabinoid drug molecule while its methyl-
ated analog Me-v8-THC is almost devoid of any
biological activity.
Hitherto, our biophysical studies were focused in a
simple phospholipid bilayer system. In this study, we
extended the complexity of the membrane bilayers by
incorporating cholesterol, a well-known vital constit-
uent of membrane bilayers.
The present study reveals di¡erential e¡ects be-
tween the pair of cannabinoids under study. The ac-
tive cannabinoid when it is incorporated into the
membrane causes more drastic changes. In particu-
lar, it a¡ects more the phase properties of DPPC/
CHOL bilayers vis a' vis the inactive analog. For
Fig. 6. 13C/MAS-NMR spectra of aromatic and carbonyl regions of membrane bilayers DPPC/CHOL, DPPC/CHOL/v8-THC and
DPPC/CHOL/Me-v8-THC.
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example, the broadening of the phase transition is
more signi¢cant when the active v8-THC is incorpo-
rated in the DPPC/CHOL meaning that it decreases
more the cooperativity of DPPC/CHOL membrane
bilayer. The DSC data show di¡erent e¡ects of the
pair of cannabinoids under study on the thermo-
tropic properties of DPPC/CHOL bilayers that de-
pend both on cholesterol and drug concentration. In
both cases, the e¡ects are more pronounced in mem-
brane bilayers containing the active cannabinoid
than the membrane bilayers containing the inactive
one.
An important feature observed solely in bilayers
containing cholesterol and the active cannabinoid
v8-THC was the appearance of a peak centered at
28.5‡C. This peak was observed also by Bruggemann
et al. [22] using similar preparations of PC/v9-THC
without and with cholesterol samples. The authors
explained this peak as a not simple association or
complex between PC/v9-THC. When a membrane
bilayer is without cholesterol this peak is evident
only when v8-THC is incorporated at xv 0.10 [9].
However, in the presence of cholesterol this peak is
evident even when v8-THC is added at x = 0.05. This
means that cholesterol enhances the association of
v8-THC with DPPC. The thermogram of DPPC/
CHOL (x = 0.20)/v8-THC (x = 0.10) con¢rms the
above observation because it resembles with that of
DPPC/v8-THC (x = 0.20). At higher cholesterol con-
tent (x = 0.30), this peak is absent in preparations
Fig. 7. Molecular graphics showing the topography of v8-THC in DPPC/CHOL bilayers.
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containing either v8-THC or Me-v8-THC. It appears
that cholesterol acts di¡erently at high concentra-
tions in a lipid environment containing cannabinoid.
An explanation for this may be that cholesterol at
high concentrations associates with DPPC. Thus, it
prevents the association of cannabinoid with phos-
pholipid.
13C-NMR spectroscopy was widely used for the
study of DPPC phospholipid bilayers with or with-
out cholesterol and also other additives [26^37].
However, examples of the use of this technique for
comparison of pairs of drugs possessing distinct dif-
ferent biological activity are not found in the litera-
ture.
We believe that such experiments are mainly im-
portant for two reasons: (a) they may provide insight
on the molecular mechanism of action of a drug at
membrane level ; and (b) examine the sensitivity of
MAS technique to provide information on the phys-
icochemical parameters that govern drug^membrane
interactions.
The 13C-NMR experiments showed that the active
analog positions itself in a di¡erent topography than
the inactive analog. More speci¢cally, the obtained
data point out that the active analog is anchored in
mesophase-polar region of membrane bilayer while
the inactive analog in the hydrophobic region. This
explains the less drastic e¡ects caused by Me-v8-
THC on DPPC/CHOL bilayers. It also explains its
high mobility in this region of the membrane. In
Fig. 8. Molecular graphics showing the topography of Me-v8-THC in DPPC/CHOL bilayers.
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contrast, the active one which is anchored in the
mesophase-polar region with its phenolic hydroxyl
group probably hydrogen bonding with phosphate
groups or water molecules has a limited £exibility.
In conclusion, the obtained results suggest that
DPPC/CHOL bilayers can serve as a matrix to ex-
plain the di¡erential e¡ects of the pair of cannabi-
noids which have distinctly di¡erent activity. The
obtained data suggest that the biological action of
cannabinoids may ¢rst be screened in the core of
the membrane bilayer before they laterally di¡use
into the receptor site. It is apparent that if such pos-
tulation is true, the topography and orientation of
cannabinoids into the membrane bilayers as revealed
in our studies are important factors that govern their
activities.
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